# Cancer Biology Research (93.396)

Source: https://welltoldgrants.com/programs/93-396-cancer-biology-research/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Cancer Biology Research is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $4.3 billion in 3,142 grants, about $1.4 million per award.

## Objectives

To provide fundamental information on the cause and nature of cancer in people, with the expectation that this will result in better methods of prevention, detection and diagnosis, and treatment of neoplastic diseases. Cancer Biology Research includes the following research programs: cancer cell biology; cancer immunology, hematology and etiology; DNA and chromosomal aberrations; tumor biology and metastasis; and structural biology and molecular applications.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $795 million | 1,699 |
| 2022 | $838 million | 1,790 |
| 2023 | $878 million | 1,814 |
| 2024 | $873 million | 1,802 |
| 2025 | $914 million | 1,634 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| The Trustees of Columbia University in the City of New York | New York | $151 million |
| The Univeristy of Texas M.D. Anderson Cancer Center | Texas | $144 million |
| Sloan-Kettering Institute for Cancer Research | New York | $136 million |
| Dana-Farber Cancer Institute, Inc. | Massachusetts | $107 million |
| The Regents of the University of California, San Francisco | California | $95.5 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | $91.1 million |
| Weill Medical College of Cornell University | New York | $86.8 million |
| The Leland Stanford Junior University | California | $85.3 million |
| University of California, San Diego | California | $85.0 million |
| The Washington University | Missouri | $81.0 million |
| Regents of the University of Michigan | Michigan | $78.6 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | $70.9 million |
| Icahn School of Medicine at Mount Sinai | New York | $67.9 million |
| Baylor College of Medicine | Texas | $67.4 million |
| The University of Texas Southwestern Medical Center | Texas | $67.1 million |
| New York University | New York | $67.0 million |
| Yale Univ | Connecticut | $65.1 million |
| H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. | Florida | $62.7 million |
| Duke University | North Carolina | $62.5 million |
| The Johns Hopkins University | Maryland | $61.7 million |

## Open opportunities

- [NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-24-011-nih-research-software-engineer-rse-award-r50-clinical/), closes December 4, 2026
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-24-214-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2027
- [Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-221-population-approaches-to-reducing-alcohol-related-cancer/), closes January 7, 2027
- [Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ca-28-013-carcinogen-hazard-assessment-monographs-program-champ-r01/), closes February 9, 2027
- [New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-272-new-approaches-for-measuring-brain-changes-across-longer/), closes May 7, 2027
- [New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-279-new-approaches-for-measuring-brain-changes-across-longer/), closes May 7, 2027
- [Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-254-change-of-recipient-organization-type-7-parent-clinical/), closes July 12, 2027
- [Successor-in-Interest (Type 6 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-253-successor-in-interest-type-6-parent-clinical-trial/), closes July 17, 2027
- [NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-080-nih-support-for-conferences-and-scientific-meetings-parent/), closes September 7, 2027
- [Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ca-27-019-early-stage-development-of-informatics-technologies-for/), closes October 19, 2027
- [Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-043-mechanisms-that-impact-cancer-risk-after-bariatric-surgery/), closes January 7, 2028
- [Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-044-mechanisms-that-impact-cancer-risk-after-bariatric-surgery/), closes January 7, 2028
- [Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-311-molecular-imaging-of-inflammation-in-cancer-r01-clinical/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-148-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)](https://welltoldgrants.com/grants/par-25-292-the-role-of-work-in-health-disparities-in/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-134-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-298-research-enhancement-award-program-reap-for-health/), closes January 7, 2028
- [Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-321-exploratory-developmental-bioengineering-research-grants/), closes January 7, 2028
- [Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-346-exploratory-developmental-bioengineering-research-grants/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-304-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)](https://welltoldgrants.com/grants/pa-25-306-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-301-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)](https://welltoldgrants.com/grants/pa-25-168-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 4, 2028
- [Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-324-method-to-extend-research-in-time-merit-award/), closes September 7, 2028
- [The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-26-134-the-metastasis-research-network-metnet-metnet-research/), closes November 22, 2028
- [Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-001-administrative-supplements-to-existing-nih-grants-and/), closes November 30, 2028
- [NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-002-nih-collaborative-international-research-project-parent-pf5/), closes May 7, 2029
- [Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-28-090-centers-for-aids-research-cfar-and-developmental-centers/), closes May 25, 2029
- [NIH Research Program Projects (Parent P01 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-061-nih-research-program-projects-parent-p01-clinical-trial/), closes May 25, 2029
- [Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-072-bioengineering-research-grants-brg-r01-clinical-trial/), closes July 5, 2029
- [NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-088-nci-research-specialist-award-for-core-and-laboratory/), closes not stated
- [Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-009-single-source-coordinating-center-cc-for-the-small/), closes not stated
- [Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ca-28-003-advanced-development-and-sustainment-of-informatics/), closes not stated
- [Investigator-Focused Award (Parent R35)](https://welltoldgrants.com/grants/par-28-037-investigator-focused-award-parent-r35/), closes not stated